KAuShIK SuNDer rAjAN
epilogUe
threaDs anD artiCuLations
The chapters in this volume traverse an array of empirical material (ge-
nomics, pharmaceutical marketing, intellectual property, environmental
science, clinical trials, and patient advocacy, to name but some); draw on
practices that are happening around the world (North and South America,
Europe, Africa, South and Southeast Asia are all represented); and adopt a
variety of disciplinary approaches. I wish in this brief concluding overview
to thread together some of those themes. The attempt here is not to create
a unifying framework. Indeed, I think that an attempt to do so would be an
impoverishment that would not do justice to the richness and range of em-
pirical material that the authors are contending with. Rather, I wish to high-
light some points of convergence, divergence, and distinction that mark this
collection.1 I wish to do this by working through nine specific points that
resonate for me in the chapters collected here.
These concern a series of questions that are empirical, methodological,
and political (where these three categories cannot be easily teased apart from
one another). Empirically—what are these things that we are seeing in the
world of technocapital today, and in what ways are they new or do they force
a recalibrating of the vocabulary of social theory that we have inherited?
Methodologically—how do we see these things and write about them in ways
Previous Page Next Page